15th September 2021 | Pharma Updates
BDR launches generic cancer drug in India
Cabozantinib is indicated for the treatment of metastatic medullary thyroid cancer, hepatocellular carcinoma and advanced renal cell carcinoma.
Acute segment helps pharma companies
Growth in the Indian drug market was robust in July and August at 18.3% and 15.4% respectively.
Pharma company employee killed in accident
A 34-year-old pharma employee was killed in a road accident in the Naubasta area of Kanpur.
Roche won’t contest Hetero Drug’s tocilizumab copy
Roche has said pharma companies in low and middle-income countries to produce tocilizumab can do so without the delay of licensing negotiations.
Temasek in the conversation for 40% stake in Integrace
Temasek will invest around Rs 550 cr in Integrace at a valuation of about 1200 cr, people aware of the matter said.
Laurus Labs and partners to make pediatric HIV drug
Laurus Labs has entered into an agreement to accelerate the development of second and third-line HIV medication.
Glenmark Pharma completes PMS study on Fabiflu
The drug company has successfully completed the post-marketing surveillance study on Fabiflu in India.
